[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-350573-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-350573-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","peptides-as-integrative-modulators-for-clinical-prognosis-and-targeted-therapy-in-pancreatic-cancer-review","Peptides as integrative modulators for clinical prognosis and targeted therapy in pancreatic cancer - Review","","Pancreatic cancer is a major global health challenge, with low 5-year survival driven by late-stage diagnosis and limited options. This comprehensive review evaluates peptides as biomarkers and prognostic indicators to close gaps in early detection and personalized management. It synthesizes evidence from molecular oncology, proteomics, and bioinformatics, covering key genetic drivers and peptide sources including neoantigens, stromal fragments, and immune-modulating signals via exosomes and ectodomain shedding. It also highlights discovery pipelines using mass spectrometry, immunoassays, and machine learning validation, emphasizing candidates such as PF4, PRO-C11-511, and CXCL7 that can improve diagnostic accuracy and outcome prediction when combined with CA19-9.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/peptides-as-integrative-modulators-for-clinical-prognosis-and-targeted-therapy-in-pancreatic-cancer-review/350573/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/peptides-as-integrative-modulators-for-clinical-prognosis-and-targeted-therapy-in-pancreatic-cancer-review/350573.png","ImageObject",300,407,{"name":42,"@type":43},"Blitz","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is early detection of pancreatic cancer difficult?","Question",{"text":63,"@type":64},"Patients often show no symptoms in the initial stages, so the disease is frequently undetected until it reaches more severe, often metastatic, stages. When symptoms appear, they can be vague and overlap with other digestive disorders, complicating identification.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What peptides are discussed as potential biomarkers and prognostic indicators?",{"text":68,"@type":64},"The review explores peptides derived from tumor neoantigens, stromal remodeling fragments, and immune-modulating signals released through mechanisms such as ectodomain shedding and exosomes. It emphasizes how these peptide sources can reflect disease progression and microenvironment changes.",{"name":70,"@type":61,"acceptedAnswer":71},"How are peptide candidates validated in the review?",{"text":72,"@type":64},"Validation is described across advanced pipelines including mass spectrometry-based proteomics, immunoassays, and machine learning-driven analysis. The review highlights candidates such as PF4, PRO-C11-511, and CXCL7, including performance metrics when integrated with established markers like CA19-9.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},350573,1790643087,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},24464137899374,"https://us-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Yadav etal. Discover Oncology (2026) 17:1008 Discover Oncology  \n[https://doi.org/10.1007/s12672-026-05130-w](https://doi.org/10.1007/s12672-026-05130-w)  \nREVIEW Open Access  \nPeptides as integrative modulators for clinical  prognosis and targeted therapy in pancreatic cancer  \nBhawana Yadav1, Shiva Prasad Kollur2*, Amena Ali3, Payas Arora1, Aanika Gupta1, P. Saranraj4, Vijay Jagdish Upadhye5* and Pallavi Singh1*  \n*Correspondence:  \nShiva Prasad Kollur [shivaprasad.k@myamrita.edu.in](shivaprasad.k@myamrita.edu.in)[ ](shivaprasad.k@myamrita.edu.in)Vijay Jagdish Upadhye  \nvijay.upadhye35296@ [paruluniversity.ac.in](paruluniversity.ac.in)  \nPallavi Singh [pallavisingh.bt@geu.ac.in](pallavisingh.bt@geu.ac.in)[ ](pallavisingh.bt@geu.ac.in)1Department of Biotechnology, Graphic Era (Deemed to be University), Dehradun, Uttarakhand 248002, India 2School of Physical Sciences, Amrita Vishwa Vidyapeetham, Mysuru Campus, Mysuru, Karnataka 570026, India  \n3Department of Biotechnology, Jaypee Institute of Information Technology, Noida,  \nUttar Pradesh 201309, India  \n4PG and Research Department of Microbiology, Sacred Heart College (Autonomous), Tirupattur,  \nTamil Nadu 635601, India 5Research and Development cell, Department of Microbiology, Parul Institute of Applied Sciences (PIAS), Parul University, Vadodara, Gujarat 391760, India  \nAbstract  \nPancreatic cancer remains a formidable global health challenge, ranking as the twelfth most common malignancy yet claiming an outsized toll with dismal 5-year survival rates 13. 3%, largely due to late-stage diagnosis and limited therapeutic options. This comprehensive review delves into the transformative potential of peptides as innovative biomarkers and prognostic indicators, addressing the critical gaps in early detection and personalized management of this aggressive disease. Drawing from cutting-edge research in molecular oncology, proteomics, and bioinformatics, this paper highlights key genetic drivers such as KRAS, TP53, CDKN2A, and SMAD4 mutations that fuel Pancreatic cancer progression and stromal desmoplasia. Diverse peptide sources, including tumor-derived neoantigens, stromal remodeling fragments, and immune-modulating signals and their release mechanisms via ectodomain shedding and exosomes, were explored. Emphasizing advanced discovery pipelines, from mass spectrometry-based proteomics to immunoassays and machine learning-driven validation, current work spotlights promising candidates like PF4, PRO-C11-511, and CXCL7, which enhance diagnostic accuracy (AUC up to 0. 961) and predict outcomes when integrated with established markers like CA19-9 . By overcoming limitations of current biomarkers, such as low specificity and stage-dependency. This review underscores peptides’ role in revolutionizing precision oncology, paving the way for non-invasive screening, targeted therapies, and improved survival in pancreatic cancer patients.  \nKeywords Early detection, CA19-9, Chemotherapy response, KRAS mutations, Machine learning, Molecular profiling, Pancreatic cancer, Peptide biomarkers, Tumor microenvironment  \n1 Introduction  \nGlobally, pancreatic cancer is the twelfth most prevalent cancer in diagnosis frequency, while in the United States, it contributes roughly 3% to all cancer diagnoses and approximately 8% to all cancer-related fatalities [1]. The GLOBOCAN 2022 report published by the International Agency for Research on Cancer (IARC) has recorded that India  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article o","cbCais9us8w9GhkB","https://ap.wps.com/l/cbCais9us8w9GhkB","pdf",2715024,38,"English","# Abstract\n# Keywords\n# 1 Introduction\n## Global epidemiology and unmet needs\n# Licensing information","[{\"question\":\"Why is early detection of pancreatic cancer difficult?\",\"answer\":\"Patients often show no symptoms in the initial stages, so the disease is frequently undetected until it reaches more severe, often metastatic, stages. When symptoms appear, they can be vague and overlap with other digestive disorders, complicating identification.\"},{\"question\":\"What peptides are discussed as potential biomarkers and prognostic indicators?\",\"answer\":\"The review explores peptides derived from tumor neoantigens, stromal remodeling fragments, and immune-modulating signals released through mechanisms such as ectodomain shedding and exosomes. It emphasizes how these peptide sources can reflect disease progression and microenvironment changes.\"},{\"question\":\"How are peptide candidates validated in the review?\",\"answer\":\"Validation is described across advanced pipelines including mass spectrometry-based proteomics, immunoassays, and machine learning-driven analysis. The review highlights candidates such as PF4, PRO-C11-511, and CXCL7, including performance metrics when integrated with established markers like CA19-9.\"}]","Peptides as integrative modulators for clinical prognosis and targeted therapy in pancreatic cancer - Review | PDF",1790089670,96,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2ca11dca1a5fa0fed6ec426293367fdc.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9e3042a71978e1140f176d5b083341bc.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/82818885fd3628d3a24fba9d90f69945.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2877f72f29f343dd0ea9668110e51ee0.webp",980,1306]